|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-3-18
|
|
pubmed:abstractText |
The objective of our study was to determine the clinical relevance of cyclin D1 expression in hormone receptor-positive breast cancer patients who were treated with tamoxifen-based therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:Austrian Breast and Colorectal Cancer Study Group,
pubmed-author:DietzeOttoO,
pubmed-author:FilipitsMartinM,
pubmed-author:GnantMichael F XMF,
pubmed-author:GreilRichardR,
pubmed-author:GrillRenateR,
pubmed-author:HuynhAnhA,
pubmed-author:JakeszRaimundR,
pubmed-author:KwasnyWernerW,
pubmed-author:LaxSigurdS,
pubmed-author:LehnertMartinaM,
pubmed-author:RudasMargarethaM,
pubmed-author:SchippingerWalterW,
pubmed-author:SingerChristianC,
pubmed-author:StiererMichaelM,
pubmed-author:StiglbauerWolfgangW
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1767-74
|
|
pubmed:meshHeading |
pubmed-meshheading:18347178-Adult,
pubmed-meshheading:18347178-Aged,
pubmed-meshheading:18347178-Aged, 80 and over,
pubmed-meshheading:18347178-Aminoglutethimide,
pubmed-meshheading:18347178-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18347178-Breast Neoplasms,
pubmed-meshheading:18347178-Chemotherapy, Adjuvant,
pubmed-meshheading:18347178-Cyclin D1,
pubmed-meshheading:18347178-Cyclophosphamide,
pubmed-meshheading:18347178-Disease-Free Survival,
pubmed-meshheading:18347178-Female,
pubmed-meshheading:18347178-Fluorouracil,
pubmed-meshheading:18347178-Follow-Up Studies,
pubmed-meshheading:18347178-Goserelin,
pubmed-meshheading:18347178-Humans,
pubmed-meshheading:18347178-Methotrexate,
pubmed-meshheading:18347178-Middle Aged,
pubmed-meshheading:18347178-Prognosis,
pubmed-meshheading:18347178-Receptors, Cytoplasmic and Nuclear,
pubmed-meshheading:18347178-Recurrence,
pubmed-meshheading:18347178-Tamoxifen,
pubmed-meshheading:18347178-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.
|
|
pubmed:affiliation |
Department of Pathology, Medical University of Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|
